Tonix Pharmaceuticals Holding Corp. (TNXP)
NASDAQ: TNXP · Real-Time Price · USD
11.37
-0.15 (-1.35%)
Jun 16, 2026, 12:25 PM EDT - Market open
Tonix Pharmaceuticals Holding Employees
Tonix Pharmaceuticals Holding had 142 employees as of December 31, 2025. The number of employees increased by 61 or 75.31% compared to the previous year.
Employees
142
Change (1Y)
61
Growth (1Y)
75.31%
Revenue / Employee
$123,634
Profits / Employee
-$1,037,930
Market Cap
181.17M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 142 | 61 | 75.31% |
| Dec 31, 2024 | 81 | -22 | -21.36% |
| Dec 31, 2023 | 103 | -14 | -11.97% |
| Dec 31, 2022 | 117 | 44 | 60.27% |
| Dec 31, 2021 | 73 | 47 | 180.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Innate Pharma | 164 |
| MediWound | 121 |
| Alector | 103 |
| Immunic | 92 |
| Acumen Pharmaceuticals | 61 |
| Milestone Pharmaceuticals | 38 |
| NovaBridge Biosciences | 30 |
| AN2 Therapeutics | 21 |
TNXP News
- 5 days ago - Tonix Pharmaceuticals to Attend BTIG Infectious Disease Day 2026 - GlobeNewsWire
- 8 days ago - Tonix Pharmaceuticals secures second commercial agreement for Tonmya - TheFly
- 8 days ago - Tonix Pharmaceuticals Secures Second Commercial Payer Agreement for TONMYA®, Expanding Total Commercial Coverage to ~52 Million U.S. Lives - GlobeNewsWire
- 15 days ago - Tonix Pharmaceuticals Holding Slides: Investor presentation - Filings
- 18 days ago - Tonix presents data from analysis of opioid use in adults with fibromyalgia - TheFly
- 18 days ago - Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis of Opioid Use in Patients with Fibromyalgia at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting - GlobeNewsWire
- 20 days ago - Tonix Pharmaceuticals publishes TNX-1500 data in Journal of Clinical Immunology - TheFly
- 20 days ago - Tonix Pharmaceuticals Announces Publication of Phase 1 Clinical Data of TNX-1500, an Fc-Modified anti-CD40L (CD154) Monoclonal Antibody, in the Peer-Reviewed Journal of Clinical Immunology - GlobeNewsWire